Is there any place for oral anti-restenotic treatment in the era of drug eluting stents?
Are drug eluting stents destined to become the standard of care for all patients undergoing percutaneous coronary intervention, or are alternative therapeutic approaches preferable under certain circumstances?
Gershlick
A H
AH
D000284:Administration, Oral; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000925:Anticoagulants / Q000008:administration & dosage*; D001026:Coronary Artery Bypass / Q000379:methods; D023903:Coronary Restenosis / Q000517:prevention & control*; D004343:Drug Implants; D006801:Humans; D015607:Stents
D000925:Anticoagulants; D004343:Drug Implants